drugset / Trial / NCT00758836
A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will test the safety and how effective telcagepant is when taken with ibuprofen or acetaminophen in participants with migraine with or without aura. The primary study hypothesis is that at least one drug combination is superior to telecagepant alone in the treatment of acute migraines.
Timeline
- Start
- 2008-12-03
- Primary completion
- 2009-08-24
- Completion
- 2009-08-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 1000 mg | Oral |
| Subject | Ibuprofen | Small molecule | 400 mg | Oral |
| Subject | Telcagepant | Small molecule | 280 mg | Oral |